Wedbush analyst Dan Ives not too long ago listed a high-profile prediction that the Trump administration will “make an fairness funding in a quantum computing firm,” naming IonQ (IONQ) and Rigetti (RGTI) as possible targets. Information of this forecast, a part of Ives’ 2026 tech outlook, added to investor curiosity in IonQ. The remark, a part of Ives’ broader 2026 tech outlook, didn’t set off a breakout rally, but it surely did what these calls usually do: it pulled IonQ again into the market’s highlight.
IonQ shares traded within the high-$40s in mid-December, barely greater than the place the inventory sat earlier than the prediction circulated. The response was restrained, which is telling. Traders have heard big-picture quantum guarantees earlier than, and lots of now look ahead to proof slightly than headlines.
To date in 2025, IonQ is up about 28% yr to this point (YTD), although that quantity masks excessive swings. The inventory surged to just about $84 in October earlier than giving again roughly 45% of these good points. That sample tells us how these quantum names commerce as optimism runs quick, however conviction fades simply as rapidly when new info fails to alter the basics. Acquisitions, partnerships, and bullish analyst notes have supported sentiment, however none have but resolved the profitability query.
www.barchart.com
The Trump prediction itself doesn’t alter IonQ’s enterprise outlook right now. There is no such thing as a contract, no funding dedication, and no timeline. Nonetheless, the concept issues. Authorities backing could be significant for a corporation like IonQ, significantly if it results in defense- or national-security-related work. That form of buyer brings scale, long-term visibility, and credibility that few business consumers can match.
For now, the transfer seems pushed extra by curiosity than capital. Traders ought to know that IonQ’s value motion continues to hinge on speculative curiosity tied to the promise of quantum computing slightly than measurable working progress. The actual check will come when pleasure fades and traders give attention to whether or not IonQ can constantly develop business income and slim losses.
Till then, the headlines might transfer the inventory, however execution will determine whether or not these strikes final.
IonQ’s most up-to-date quarterly report for Q3 2025 confirmed fast top-line progress however continued heavy losses. The corporate reported income of $39.86 million, up 222% year-over-year (YoY) and properly above the excessive finish of administration’s steering, pushed largely by current acquisitions, together with Capella House and ID Quantique, in addition to expanded quantum providers.
Profitability, nonetheless, stays elusive. IonQ posted a web lack of roughly $1.1 billion, sharply wider than a yr earlier, primarily resulting from non-cash stock-based compensation and elevated analysis and growth spending. Adjusted EBITDA loss widened to about $48.9 million.
On an adjusted foundation, the loss was about -$0.17 per share, in contrast with -$0.11 a yr earlier.
Regardless of these heavy losses, the corporate ended the quarter with $1.5 billion in money and equivalents, and following its October inventory providing, professional forma liquidity stands close to $3.5 billion, offering a multi-year funding runway.
Trying forward, IonQ raised its full-year 2025 income outlook to roughly $106 million to $110 million whereas sustaining expectations for a large adjusted EBITDA lack of $206 million to $216 million.
Wall Avenue stays divided on IONQ inventory. Some analysts see long-term upside, whereas others urge persistence.
J.P. Morgan reiterated an “Equal-Weight” score and raised its value goal to $58. The agency pointed to current acquisitions and mentioned administration sounded extra assured about new government-backed quantum applications.
Goldman Sachs saved a “Maintain” score. The agency mentioned IonQ should present stronger, extra constant income progress earlier than the valuation seems justified.
Mizuho Securities took a extra bullish view. It initiated protection with an “Outperform” score and a $90 goal. Mizuho known as IonQ a number one quantum participant and highlighted its trapped-ion expertise, which it believes affords decrease error charges and higher long-term efficiency.
Total, the consensus score is “Reasonable Purchase” from 13 analysts overlaying the inventory, and the imply value goal sits at round $75.50, which suggests 42% upside potential.
www.barchart.com
On the date of publication, Nauman Khan didn’t have (both instantly or not directly) positions in any of the securities talked about on this article. All info and knowledge on this article is solely for informational functions. This text was initially printed on Barchart.com
